Donald Tashkin, MD, FCCP, ATSF

Title: Distinguished Emeritus Professor of Medicine
Company: David Geffen School of Medicine at UCLA
Location: Los Angeles, California, United States

Donald Tashkin, MD, Distinguished Emeritus Professor of Medicine at the David Geffen School of Medicine at UCLA, with nearly 50 years of academic service as an educator, researcher and clinician, has been recognized by Marquis Who’s Who Top Doctors and Top Educators for dedication, achievements, and leadership in medical education.

With nearly 50 years of professional experience, Dr. Tashkin has held a number of academic positions with the David Geffen School of Medicine at UCLA (formerly the University of California Los Angeles School of Medicine), having been recognized as professor emeritus since 2012. He previously served as Director of the Clinical Pulmonary Function Laboratory at the UCLA Medical Center for approximately 30 years. Prior to his retirement, he was a professor of pulmonary and critical care medicine for the school from 1981 to 2012, having been an associate professor since 1971 and an assistant professor since 1969. He previously held a fellowship in chest disease and pulmonary physiology with the University of California Los Angeles School of Medicine from 1967 to 1969. He served as a resident in internal medicine with the Philadelphia Veteran Affairs Hospital from 1962 to 1965 and as a rotating intern with the Albert Einstein Medical Center from 1961 to 1962. Dr. Tashkin holds a Doctor of Medicine degree from the University of Pennsylvania.

Dr. Tashkin’s research interests include the evaluation and treatment of scleroderma-related interstitial lung disease, as well as the pathophysiology, prevention and treatment of COPD, the pathophysiology and clinical pharmacology of asthma, the pulmonary effects of abuse of smoked substances (including marijuana, crack cocaine and tobacco) and of community air pollution. With regard to his marijuana-related research, Dr. Tashkin was nearly continuously funded by the National Institute on Drug Abuse (NIDA/NIH) for over 30 years to investigate the impact of marijuana smoking on the lung. He has published 579 peer-reviewed articles, mainly in top-rated journals. He is a member of the Editorial Boards of Chest, Respiratory Research, Respiratory Medicine and the Journal of the COPD Foundation, Guest Editor for numerous leading scholarly medical journals and Chair of the External Advisory Committee for the American Lung Association Airways Clinical Research Centers. He has also served as a member or Chair of several Data and Safety Monitoring Boards (including several American Lung Association Airways Clinical Research Centers clinical trials). In addition, he served as a reviewer for the 2017 report by the National Academies of Sciences, Engineering and Medicine on the Health Effects of Cannabis and Cannabinoids, a contributor to the World Health Organization’s 2015 report on The Health and Social Effects of Non-Medical Cannabis Use and a reviewer of cannabis-related grants for NIDA/NIH and the University of California Center for Medicinal Cannabis Research.

For more information, please visit:

Press Release

Contact Dr. Tashkin:

Leave a Reply